Compugen (CGEN) Gross Profit Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 403.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 403.45% |
| Dec 31, 2025 | -99.99% |
| Sep 30, 2025 | -98.22% |
| Jun 30, 2025 | -107.92% |
| Mar 31, 2025 | -125.38% |
| Dec 31, 2024 | -97.47% |
| Dec 31, 2023 | 382.07% |
| Dec 31, 2016 | -99.75% |
| Sep 30, 2016 | 75.00% |
| Jun 30, 2016 | 446.67% |
| Mar 31, 2016 | -90.84% |
| Dec 31, 2015 | 30.76% |
| Sep 30, 2015 | -97.13% |
| Jun 30, 2015 | -93.21% |
| Mar 31, 2015 | -90.48% |
| Dec 31, 2014 | 476.68% |
| Sep 30, 2014 | 681.60% |
| Jun 30, 2014 | 1,882.26% |
| Mar 31, 2014 | 11,366.67% |
| Dec 31, 2013 | 2,938.24% |
| Sep 30, 2013 | 66.67% |
| Dec 31, 2010 | 556.00% |